Accelerate your business with Oracle’s contract research organization (CRO) Growth Initiative
Gain a competitive edge, win more sponsor business, and execute more clinical trials efficiently and cost effectively with Oracle’s CRO Growth Initiative.
Accelerate your business
In the world of clinical research, speed, while maintaining quality and safety, is crucial. We recognize CROs are racing to attract and win more sponsor business, so we designed Oracle’s CRO Growth Initiative to include an accelerator. It provides you with unique go-to-market benefits, technical enablers, and incentives that empower you to plan, execute, measure, and reward your success in delivering your expert services with the industry’s leading clinical technology platform, Oracle Life Sciences Clinical One.
What are the benefits?
Partnership management
Dedicated CRO-focused resources to help accelerate your services growth and success based on a mutually agreed business strategy.
Free training and enablement
Clinical One accreditation and flexible and robust training programs to help build sales and services expertise to win new business.
Business development support
Go-to-market strategy to help elevate your brand and RFx support for joint selling and bid defenses.
Growth incentives
Clinical One single trial service credits and a free non-production Clinical One cloud environment for 12 months.
Why Oracle?
Oracle is committed to providing innovative, future-proof clinical and safety solutions that support crucial services that you provide throughout the clinical development lifecycle—from study design and startup to conduct, closeout, and post-marketing. Gain a competitive edge to win more business using proven and trusted clinical systems that can support any trial size and therapeutic area to meet the needs of your customers and patients.
About 10M
adverse events processed last year
406
unique health authorities were data beneficiaries
91%
of all vaccine adverse events reported to the FDA1
More than 3M
safety cases supported last year from a single client2
More than 250K
total clinical studies managed
28 of 30
top pharmaceutical companies worldwide use Oracle clinical systems
1 Vaccine Adverse Event Reporting System (VAERS) publicly available datasets, 2017 to 2022 week 19.
2 Data from single customer.
Why are CROs collaborating with Oracle to grow their business?
“The free enablement and non-production environment for Clinical One has empowered our study build team and data managers to become SMEs in a very short timeframe which allows Accelsiors to deliver successful studies to their sponsors.”
“Oracle's CRO Growth Initiative has elevated Oracle's commitment to CROs in reducing the barriers to adopting new technology to meet the needs of our customers, all at no risk to us.”
“We're excited to join the CRO Growth Initiative. With no risk, trials credits, and additional support, it just made good business sense.”
“FHI Clinical chose Oracle's Clinical One platform as our default clinical system because it is built the way we would have built for ourselves - single data source, united platform, intuitive, and cost efficient.”
“As a growing CRO, we are excited that Oracle, Oracle's CRO Growth Initiative and Clinical One are supporting our business goals to grow and address new markets.”
Get started with Oracle’s CRO Growth Initiative
Contact us
Please contact us to inquire about participating in the CRO Growth Initiative.